FDA Import Refusal AEK-7449258-6/30002/1 — Blue Cross Laboratories

Blue Cross Laboratories — FEI 3004617257

The FDA refused shipment AEK-7449258-6/30002/1 from Blue Cross Laboratories (India) on Aug 11, 2025. The refused product falls under Drugs and Biologics — GLIMEPIRIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
Aug 11, 2025
Country
India
Product Category
Drugs and Biologics
Product Code
61PCY31 GLIMEPIRIDE (ANTI-DIABETIC)
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.